Pfizer, eSampling Australia

Business Challenge

Pfizer is one of the world's largest pharmaceutical companies by revenues. Their global portfolio includes medicines and vaccines as well as many of the world's best-known consumer healthcare products such as Advil, ChapStick and Centrum. With the number of sales reps actually seeing doctors decreasing, pharmaceutical companies were looking for easier ways to reach doctors and provide them with samples, while making the experience more customer-centric.

Our Approach

Our team worked with Pfizer to develop their eSampling application for the Australian market, to reach more prescribers, increasing brand awareness and drive prescriptions. eSampling is an application that allows health care professionals to order product samples or resources 24/7 based on their eligibility. 

At first, only available in the U.S. and Canada, Australia is now the third market in the world that has this capability. Unlike the Canadian or US version of eSampling, the Australian version is a responsive site and has a great feature where the user can draw their signature to place their orders either using a mouse on desktop, or finger/stylus on a touchscreen device.

Customer Outcome

Physicians now have an innovative, secure and compliant digital tool, and orders can be placed from a company’s professional site, doctor’s smartphone or iPad, and completed with an electronic signature. Doctors can choose to opt-in to receive vouchers, literature, reminders, marketing messages, and, if they request it, a visit from a live rep along with their product samples.


Increase in e-sampling program participation when transitioning to electronic signature.

Pfizer ESampling

This has been the smoothest project I have worked on in my 5 years of digital at PCH! This is a result of the collective great efforts at Tribal to work closely with the business clients on the great design, and the excellent development / project management of Appnovation.

Paul Holda

Manager - Client Partner, Business Technology, Pfizer